We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+8.96%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$73.6B
AUM Growth
+$1.15B
(+1.6%)
Cap. Flow
-$3.6B
Cap. Flow
% of AUM
-4.89%
Top 10 Holdings %
Top 10 Hldgs %
20.8%
Holding
3,102
New
50
Increased
790
Reduced
2,114
Closed
100
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$38.7M |
| 2 |
International Flavors & Fragrances
IFF
|
+$27.4M |
| 3 |
Neurocrine Biosciences
NBIX
|
+$14.7M |
| 4 |
ConocoPhillips
COP
|
+$14.5M |
| 5 |
Royalty Pharma
RPRX
|
+$9.46M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$269M |
| 2 |
Microsoft
MSFT
|
+$172M |
| 3 |
Amazon
AMZN
|
+$114M |
| 4 |
Walt Disney
DIS
|
+$62.4M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$61.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.61% |
| 2 | Financials | 14.26% |
| 3 | Healthcare | 12.86% |
| 4 | Consumer Discretionary | 12.27% |
| 5 | Industrials | 9.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MCF
2476
DELISTED
Contango Oil & Gas Co.
MCF
| $520K | ﹤0.01% |
133,382
+9,377
| +8% | +$36K |
|
2477
UroGen Pharma
URGN
$2.29B
| $518K | ﹤0.01% |
26,578
-2,070
| -7% | -$43.9K |
|
2478
Accel Entertainment
ACEL
$987M
| $514K | ﹤0.01% |
47,000
-1,505
| -3% | -$16.1K |
|
2479
Aspen Aerogels
ASPN
$518M
| $512K | ﹤0.01% |
25,176
-1,395
| -5% | -$29.4K |
|
2480
Standard BioTools
LAB
$314M
| $512K | ﹤0.01% |
113,293
-4,260
| -4% | -$23.4K |
|
2481
Precision BioSciences
DTIL
$207M
| $511K | ﹤0.01% |
1,646
-76
| -4% | -$26.6K |
|
2482
Intrepid Potash
IPI
$469M
| $511K | ﹤0.01% |
15,698
-830
| -5% | -$24.5K |
|
2483
Passage Bio
PASG
$14.1M
| $511K | ﹤0.01% |
1,461
+90
| +7% | +$38.4K |
|
2484
Citizens & Northern Corp
CZNC
$455M
| $510K | ﹤0.01% |
21,460
-520
| -2% | -$11.3K |
|
2485
Outset Medical
OM
$90.8M
| $510K | ﹤0.01% |
625
-8
| -1% | -$6.17K |
|
|
SMMF
2486
DELISTED
Summit Financial Group, Inc.
SMMF
| $507K | ﹤0.01% |
19,111
-730
| -4% | -$17.3K |
|
2487
Lindblad Expeditions
LIND
$2.22B
| $506K | ﹤0.01% |
26,794
-2,372
| -8% | -$43.2K |
|
|
CTO
2488
CTO Realty Growth
CTO
$815M
| $505K | ﹤0.01% |
29,106
-1,977
| -6% | -$32K |
|
|
EBTC
2489
DELISTED
Enterprise Bancorp
EBTC
| $505K | ﹤0.01% |
15,532
-565
| -4% | -$16.6K |
|
|
AWH
2490
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
| $505K | ﹤0.01% |
4,987
-23
| -0.5% | -$2.53K |
|
2491
BioLife Solutions
BLFS
$1.7B
| $503K | ﹤0.01% |
13,972
+335
| +2% | +$13.2K |
|
2492
Caesarstone
CSTE
$79.5M
| $503K | ﹤0.01% |
36,611
-1,220
| -3% | -$16.1K |
|
2493
MVB Financial
MVBF
$389M
| $502K | ﹤0.01% |
14,852
-795
| -5% | -$22.3K |
|
2494
American Coastal Insurance
ACIC
$493M
| $500K | ﹤0.01% |
69,353
+251
| +0.4% | +$1.6K |
|
2495
VirnetX Holding Corp
VHC
$63.1M
| $500K | ﹤0.01% |
4,491
-222
| -5% | -$27.8K |
|
|
VOXX
2496
DELISTED
VOXX International Corporation Class A
VOXX
| $500K | ﹤0.01% |
26,232
+1,111
| +4% | +$23.1K |
|
|
AMK
2497
DELISTED
AssetMark Financial Holdings, Inc.
AMK
| $499K | ﹤0.01% |
21,378
-1,269
| -6% | -$30.7K |
|
|
ZIXI
2498
DELISTED
Zix Corporation
ZIXI
| $499K | ﹤0.01% |
66,138
-3,620
| -5% | -$30.5K |
|
|
AGEN
2499
Agenus
AGEN
$290M
| $497K | ﹤0.01% |
9,316
-638
| -6% | -$46.1K |
|
2500
Rush Enterprises Class B
RUSHB
$6.14B
| $497K | ﹤0.01% |
16,541
-571
| -3% | -$15.7K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2021 Portfolio in Review
As of Q1 2021, RhumbLine Advisers held 3,102 positions worth $73.6B, up 1.6% from $72.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
RhumbLine Advisers withdrew a net $3.6B in Q1 2021, closing 100 positions and reducing 2,114 holdings. Its most notable exit was Tiffany & Co., an estimated $26.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.
Against the trend, RhumbLine Advisers opened a new position in NXP Semiconductors worth $42.7M.
- RhumbLine Advisers's largest Q1 2021 buy was NXP Semiconductors: 211,843 shares worth $42.7M.
- RhumbLine Advisers added most to International Flavors & Fragrances in Q1 2021, an estimated $27.4M increase.
- RhumbLine Advisers's biggest Q1 2021 reduction was Apple, cutting an estimated $269M.
- RhumbLine Advisers fully exited Tiffany & Co. in Q1 2021, selling an estimated $26.8M.
- RhumbLine Advisers's ten largest holdings make up 21% of its $73.6B portfolio in Q1 2021.
- RhumbLine Advisers opened 50 new positions and closed 100 in Q1 2021.
- RhumbLine Advisers's portfolio value rose 1.6% quarter-over-quarter to $73.6B.
Based on RhumbLine Advisers's 13F filing for Q1 2021, filed 6 May 2021.